Assura Declines KKR's $1.6 Billion Takeover Offer: A Closer Look

In a significant development within the real estate investment sector, UK landlord Assura has officially turned down a takeover bid from the private equity firm KKR, valued at approximately $1.6 billion. This decision has left analysts and stakeholders pondering the implications for both Assura and the broader market.

Continue reading

Chinese Health Watchdog Stands Firm on Quality of Domestic Generic Drugs Amid Rising Concerns

The Chinese National Medical Products Administration (NMPA) has recently issued a strong defense regarding the quality standards of local generic medications. This statement comes in light of growing scrutiny and skepticism towards the efficacy and safety of domestically produced pharmaceuticals. The regulatory body emphasized that ongoing rigorous quality control measures are in place to ensure that generic drugs meet international standards.

Continue reading